Product Information
DEXTROAMP-AMPHET ER 30 MG CAP is a generic product labeled by Lannett Company Inc., priced at $0.4857 per EA under NDC 00527551537. Its NADAC has been published 280 times since Oct 21, 2020.
The Low Outlier badge above means this manufacturer's average price in the Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
DEXTROAMP-AMPHET ER 30 MG CAP
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine SulfateStrength
7.5; 7.5; 7.5; 7.5 mg/1; mg/1; mg/1; mg/1
Manufacturer
Lannett Company Inc.NDC
00527551537
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
2/18/2026
Active Ingredients
AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA212037On Market Since
12/18/2019
Pharmacological Classes
Price Statistics
The NADAC for DEXTROAMP-AMPHET ER 30 MG CAP has been published 280 times since Oct 21, 2020, and over the history we have for it it has declined 48.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4857 per EA |
|---|---|
| All-time high | $0.9501 (Nov 11, 2020) |
| All-time low | $0.3360 (May 22, 2024) |
| 52-week high | $0.5944 |
| 52-week low | $0.4621 |
| Median price | $0.6331 |
| Average price | $0.6285 |
| Largest weekly change | +61.4% (Jun 19, 2024) |
| Weeks tracked | 280 |
| Tracking since | Oct 21, 2020 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 37% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DEXTROAMP-AMPHET ER 30 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHET ER 30 MG CAP, manufactured by Lannett Company Inc., is $0.4857 per EA (NDC 00527551537), effective Feb 25, 2026.
How has the price of DEXTROAMP-AMPHET ER 30 MG CAP changed over time?
Over the history we have for it, the NADAC for DEXTROAMP-AMPHET ER 30 MG CAP has declined 48.9%. It has been tracked across 280 weekly CMS publications since Oct 21, 2020.
What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHET ER 30 MG CAP?
Since Oct 21, 2020, the NADAC for DEXTROAMP-AMPHET ER 30 MG CAP has ranged from a low of $0.3360 (May 22, 2024) to a high of $0.9501 (Nov 11, 2020), with a median of $0.6331 per EA.
Are there cheaper alternatives to DEXTROAMP-AMPHET ER 30 MG CAP?
Yes. 4 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, DEXTROAMP-AMPHETAMIN 30 MG TAB, is $0.3048 per EA — about 37% below DEXTROAMP-AMPHET ER 30 MG CAP.
Who manufactures DEXTROAMP-AMPHET ER 30 MG CAP?
DEXTROAMP-AMPHET ER 30 MG CAP (NDC 00527551537) is labeled by Lannett Company Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification